<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>How Is DexCom's Performance Compared to Other Medical Device Companies?</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>How Is DexCom's Performance Compared to Other Medical Device Companies?</h1>
  <ul>
<li>DexCom registered an 11.6% growth in non-GAAP EPS to $0.48, exceeding the Street’s expectations by 6.7%.</li>
<li>Despite its strengths, DexCom stock has plunged 16.4% from its 52-week high of $93.25 touched on Feb.</li>
<li>Further, DXCM stock has experienced a marginal 30 bps uptick in 2025, lagging behind IHI’s 7.2% gains on a YTD basis.</li>
<li>Driven by solid organic growth at home and internationally, the company’s overall topline for the quarter soared 15.2% year-over-year to $1.2 billion, surpassing the consensus estimates by 3.1%.</li>
<li>More News from Barchart - This Penny Stock Just Soared 4,000% on a Key Worldcoin Investment.</li>
<li>However, the stock has soared 13.7% over the past 52 weeks, outpacing IHI’s 7.7% returns over the past year.</li>
<li>Meanwhile, the stock has dropped by 10% over the past three months, notably underperforming the industry-focused iShares U.S.</li>
</ul>
<p><a href="https://finance.yahoo.com/m/40110f5b-b462-337e-8025-e1a733746894/how-is-dexcom%27s-performance.html">Source</a> · 2025-09-09T07:28:27+00:00</p>
</body>
</html>